Roflumilast API Manufacturers

compare suppliers & get competitive offers

Filters

Reset

Selected filters:

Type
Production region
Qualifications
Country of origin

Distributor

Produced in:

World

Established in: 2005

MOQ: -

Employees: 200+

Portfolio of over 2,000 APIs

Precise quality control

End-to-end global regulatory support

  • CoA

  • GMP

  • CEP

  • FDA

  • DMF

  • + 0

All certificates

  • DMF

  • CEP

  • GMP

  • CoA

  • MSDS

  • BSE/TSE

Contact supplier

Replies quickly

Produced in:

China

Established in: 2011

MOQ: 100 g

Employees: 10+

Fast Response and Good Communication

Willingness To Start From Small

Flexible Payment Terms

  • CoA

  • GMP

  • CEP

  • FDA

  • DMF

  • + 0

All certificates

  • CoA

  • BSE/TSE

  • MSDS

Contact supplier

Replies in a day or 2

Produced in:

Unknown

Established in: 1963

MOQ: -

Employees: 800+

World’s 1st exclusive API distributor

Portfolio of 600+ APIs

>250 clients in Europe

  • CoA

  • GMP

  • CEP

  • FDA

  • DMF

  • + 0

All certificates

  • CoA

  • MSDS

  • GMP

Contact supplier

Replies quickly

Located in:

China
  • CoA

  • GMP

  • CEP

  • FDA

  • DMF

  • + 0

All certificates

  • WC

  • DMF

  • CoA

Contact supplier

Replies slower than most

Located in:

China

Producer

  • CoA

  • GMP

  • CEP

  • FDA

  • DMF

  • + 0

All certificates

  • DMF

  • CoA

Contact supplier

Replies slower than most

Located in:

India

Producer

  • CoA

  • GMP

  • CEP

  • FDA

  • DMF

  • + 0

All certificates

  • DMF

  • CoA

Located in:

India

Producer

  • CoA

  • GMP

  • CEP

  • FDA

  • DMF

  • + 0

All certificates

  • GMP

  • WC

  • CoA

  • DMF

Located in:

China

Located in:

India
  • CoA

  • GMP

  • CEP

  • FDA

  • DMF

  • + 0

All certificates

  • DMF

  • CoA

How does it work?

1
Register for free
icon

You can register for free as long as you are registering on behalf of a legal company related to the pharmaceutical industry

2
Start sourcing
icon

Search in the search bar the product that you’re looking for. We’ll show you an overview of all available suppliers. Use the filters to select the relevant suppliers only

3
Send inquiries
icon

Have you found interesting suppliers? Then it’s time to contact them. Use the send inquiry button and send them a message. You can send for each product, 3 inquiries per week

4
Get quotation
icon

Suppliers get notified by Pharmaoffer that they’ve received a new inquiry. They will come back to you with their questions, certificates, and offer in the chat on Pharmaoffer. We will send you an email in case of any news

5
Arrange agreement
icon

Does the supplier meet your quality and commercial requirements? Then you can place the order. Just follow the steps of our order module

Looking for Roflumilast API 162401-32-3?

Description:
Here you will find a list of producers, manufacturers and traders of Roflumilast. You can sort by certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
API | Excipient name:
Roflumilast 
Synonyms:
Daliresp , ROF , Roflumilastum  
Cas Number:
162401-32-3 
DrugBank number:
DB01656 
Unique Ingredient Identifier:
0P6C6ZOP5U

About Roflumilast

What can you use it for? Roflumilast is a phosphodiesterase-4 (PDE-4) inhibitor. Due to its selective inhibition of the PDE4 isoenzyme in lung cells, roflumilast is indicated for the management of chronic obstrtuctive pulmonary disease (COPD) exacerbations. Treatment with Roflumilast is associated with an increase in psychiatric adverse reactions, including suicide and suicidal attempts.

You can ask the supplier for more technical information about the product.

Roflumilast is a type of Phosphodiesterase-4 Inhibitors


Phosphodiesterase-4 (PDE-4) inhibitors belong to the subcategory of pharmaceutical active pharmaceutical ingredients (APIs) that are widely used in the treatment of various inflammatory and respiratory conditions. These inhibitors work by blocking the enzyme phosphodiesterase-4, which is responsible for breaking down cyclic adenosine monophosphate (cAMP) in cells. By inhibiting PDE-4, the levels of cAMP are increased, leading to reduced inflammation and bronchoconstriction.

PDE-4 inhibitors have shown significant therapeutic potential in the management of chronic obstructive pulmonary disease (COPD), asthma, and psoriasis. The most commonly prescribed PDE-4 inhibitor is roflumilast, which is available in oral tablet form. Roflumilast specifically targets lung tissue and effectively reduces airway inflammation and hyperresponsiveness, improving lung function and reducing exacerbations in COPD patients.

Apart from their anti-inflammatory properties, PDE-4 inhibitors have also shown promise in the treatment of other conditions such as depression, cognitive disorders, and autoimmune diseases. Ongoing research and clinical trials aim to explore the full potential of PDE-4 inhibitors in these therapeutic areas.

As with any medication, PDE-4 inhibitors may have certain side effects, including gastrointestinal disturbances (such as diarrhea and nausea), weight loss, and psychiatric effects. Therefore, careful consideration of the risks and benefits is essential before initiating treatment with PDE-4 inhibitors.

In conclusion, PDE-4 inhibitors are a subcategory of pharmaceutical APIs that hold great potential in the treatment of inflammatory and respiratory conditions. With ongoing research and development, these inhibitors may find expanded applications in various therapeutic areas, benefiting patients worldwide.


Roflumilast (Phosphodiesterase-4 Inhibitors), classified under Respiratory Tract Agents


Respiratory Tract Agents are a vital category of pharmaceutical APIs (Active Pharmaceutical Ingredients) designed to treat respiratory conditions and diseases. These agents are specifically formulated to target the respiratory system, which includes the lungs, airways, and nasal passages. They play a crucial role in managing various respiratory disorders, such as asthma, chronic obstructive pulmonary disease (COPD), and allergic rhinitis.

Respiratory Tract Agents encompass a wide range of medications, including bronchodilators, corticosteroids, antihistamines, and mucolytics. Bronchodilators are commonly used to relieve airway constriction and facilitate smooth breathing by relaxing the muscles in the airways. Corticosteroids help reduce inflammation in the respiratory system, alleviating symptoms and preventing exacerbations. Antihistamines work by blocking histamine receptors, thus mitigating allergic reactions that often impact the respiratory tract. Mucolytics aid in loosening and thinning mucus, making it easier to expel from the airways.

These APIs are developed through rigorous research and development processes, ensuring their efficacy, safety, and compliance with regulatory standards. Pharmaceutical manufacturers rely on advanced technologies and stringent quality control measures to produce high-quality Respiratory Tract Agents. These APIs are subsequently incorporated into various dosage forms, including inhalers, nasal sprays, nebulizers, and oral medications.

Respiratory Tract Agents are essential in the management of respiratory conditions, providing relief from symptoms, improving lung function, and enhancing the overall quality of life for patients. They are prescribed by healthcare professionals and often used in combination therapies to achieve optimal results. As respiratory disorders continue to affect a significant portion of the global population, the development and availability of effective Respiratory Tract Agents play a vital role in addressing these health challenges and improving patient outcomes.



Roflumilast manufacturers | traders | suppliers

We have 9 companies offering Roflumilast produced in 4 different countries.

Get in contact with the supplier of your choice:

  • LGM Pharma from United States, product country of origin World
  • Shandong Octagon Chemicals Limited from China, product country of origin China
  • TIEFENBACHER API + Ingredients from Germany, product country of origin Unknown
  • Chongqing Huapont from China, product country of origin China
  • ALP PHARM from China, product country of origin China
  • Mylan from India, product country of origin India
  • MSN Labs. from India, product country of origin India
  • Shaoxing Hantai Pharma from China, product country of origin China
  • Hetero Drugs from India, product country of origin India

Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.

You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.